{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T10:11:47Z","timestamp":1750155107917,"version":"3.33.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Dongguan social science and technology development project","award":["202050715059413"],"award-info":[{"award-number":["202050715059413"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-025-06219-y","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T01:00:16Z","timestamp":1737680416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Total marrow irradiation as part of autologous stem cell transplantation for patients with multiple myeloma"],"prefix":"10.1007","author":[{"given":"Qing-Xiu","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan-Yi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Guo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun-Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Da-Na","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Xin","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Hong","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"6219_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3760\/cma.j.issn.0253-2727.2021.01.017","volume":"42","author":"L Liu Junru","year":"2021","unstructured":"Liu Junru L, Juan H Xiaojun (2021) Problems and progress of autologous hematopoietic stem cell transplantation in multiple myeloma. Chin J Hematol 42:82\u201386. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2021.01.017","journal-title":"Chin J Hematol"},{"issue":"3","key":"6219_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1182\/blood.v99.3.731","volume":"99","author":"T Philippe Moreau","year":"2002","unstructured":"Philippe Moreau T, Facon M, Attal et al (2002) Comparison of 200 mg\/m2 melphalan and 8 gy total body irradiation plus140 mg\/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone Du Myelome 9502 randomized trial. Blood 99(3):731\u2013735. https:\/\/doi.org\/10.1182\/blood.v99.3.731","journal-title":"Blood"},{"issue":"3","key":"6219_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbmt.2005.10.026","volume":"12","author":"JY Wong","year":"2006","unstructured":"Wong JY, Liu A, Schultheiss T et al (2006) Targeted total marrow irradiation using three- dimensional image-guided tomographic intensity-modulated radiation therapy: an alternative to standard total body irradiation. Biol Blood Marrow Transpl 12(3):306\u2013315. https:\/\/doi.org\/10.1016\/j.bbmt.2005.10.026","journal-title":"Biol Blood Marrow Transpl"},{"key":"6219_CR4","doi-asserted-by":"publisher","unstructured":"Giebel S, Sobczyk-Kruszelnicka Ma\u0142gorzata, S\u0142awomir, Blamek et al (2021) Tandem autologous hematopoietic cell transplantation with sequential use of total marrow irradiation and high-dose melphalan in multiple myeloma. Bone Marrow Transplantation 56(6):1297\u20131304. https:\/\/doi.org\/10.1038\/s41409-020-01181-x","DOI":"10.1038\/s41409-020-01181-x"},{"key":"6219_CR5","doi-asserted-by":"publisher","unstructured":"Juan Jos\u00e9, Lahuerta, Carlos, Grande et al (2002) Myeloablative Treatments for Multiple Myeloma:Update of a Comparative Study of Different Regimens Used in Patients from the Spanish Registry for Transplantation in Multiple Myeloma. Leukemia & Lymphoma 43: 67\u201374.https:\/\/doi.org\/10.1080\/10428190210194","DOI":"10.1080\/10428190210194"},{"issue":"2","key":"6219_CR6","first-page":"E594","volume":"99","author":"C Han","year":"2017","unstructured":"Han C, Wong JYC, Schultheiss TE et al (2017) Comparison of radiation-induced secondary cancer occurrence rates for major organs between total body irradiation and total marrow irradiation. Int J Radiat Oncol Biol Phys 99(2):E594","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"6219_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJMoa1402888","volume":"371","author":"A Palumbo","year":"2014","unstructured":"Palumbo A, Cavallo F, Gay F et al (2014) Autologous transplantation and maintenance therapy in multiple myeloma. N Engl J Med 371(10):895\u2013905. https:\/\/doi.org\/10.1056\/NEJMoa1402888","journal-title":"N Engl J Med"},{"issue":"10192","key":"6219_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(19)31240-1","volume":"394","author":"P Moreau","year":"2019","unstructured":"Moreau P, Attal M, Hulin C et al (2019) Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma(CASSIOPEIA): a randomised, open-label, phase 3 study. Lancet 394(10192):29\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(19)31240-1","journal-title":"Lancet"},{"issue":"5","key":"6219_CR9","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3760\/cma.j.issn.0253-2727.2021.05.001","volume":"42","author":"Plasma cell Diseases Group, Society of Hematology, Chinese Medical Association, Chinese Medical Doctor Association multiple myeloma professional committee","year":"2021","unstructured":"Plasma cell Diseases Group, Society of Hematology, Chinese Medical Association, Chinese Medical Doctor Association multiple myeloma professional committee (2021) Chinese guidelines for multiple myeloma autologous hematopoietic stem cell transplantation(2021 version). Chin J Hematol 42(5):353\u2013357. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2021.05.001","journal-title":"Chin J Hematol"},{"issue":"6","key":"6219_CR10","first-page":"525","volume":"41","author":"W Zhao Xiaoyan","year":"2020","unstructured":"Zhao Xiaoyan W Huafang (2020) Application of whole bone marrow irradiation preconditioning regimen in leukemia hematopoietic stem cell transplantation. Chin J Hematol 41(6):525\u2013528","journal-title":"Chin J Hematol"},{"key":"6219_CR11","doi-asserted-by":"publisher","first-page":"5965","DOI":"10.1007\/s00432-022-04565-2","volume":"149","author":"L M\u00fcmtaz K\u00f6ksal","year":"2023","unstructured":"M\u00fcmtaz K\u00f6ksal L, Kersting F, Schoroth et al (2023) Total marrow irradiation versus total body irradiation using intensitymodulated helical tomotherapy. J Cancer Res Clin Oncol 149:5965\u20135973. https:\/\/doi.org\/10.1007\/s00432-022-04565-2","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"6219_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/153303460900800105","volume":"8","author":"P-W Shueng","year":"2009","unstructured":"Shueng P-W, Lin S-C, Chong N-S et al (2009) Total marrow irradiation with Helical Tomotherapy for bone marrow transplantation of multiple myeloma: first experience in Asia. Technol Cancer Res Treat 8(1):29\u201338. https:\/\/doi.org\/10.1177\/153303460900800105","journal-title":"Technol Cancer Res Treat"},{"key":"6219_CR13","doi-asserted-by":"publisher","unstructured":"Lin S-C, Hsieh P-Y, Shueng P-W et al (2013) Total marrow irradiation as part of autologous stem cell transplantation for Asian patients with multiple myeloma. Biomed Res Int 0321762. https:\/\/doi.org\/10.1155\/2013\/321762","DOI":"10.1155\/2013\/321762"},{"issue":"10","key":"6219_CR14","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S1470-2045(20)30342-9","volume":"21","author":"YC Jeffrey","year":"2020","unstructured":"Jeffrey YC, Wong AR, Filippi M, Scorsetti et al (2020) Total marrow and total lymphoid irradiation in bone marrow transplantation for acute leukaemia. Lancet Oncol 21(10):477\u2013487. https:\/\/doi.org\/10.1016\/S1470-2045(20)30342-9","journal-title":"Lancet Oncol"},{"issue":"19","key":"6219_CR15","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1056\/NEJMoa1114138","volume":"366","author":"Michel","year":"2012","unstructured":"Michel, Attal et al (2012) Lenalidomide Maintenance after stem-cell transplantation for multiple myeloma. N Engl J Med 366(19):1782\u20131791. https:\/\/doi.org\/10.1056\/NEJMoa1114138","journal-title":"N Engl J Med"},{"key":"6219_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1470","volume":"20","author":"H Graham","year":"2019","unstructured":"Graham H, Jackson et al (2019) Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (myeloma XI): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol 20:57\u201373. https:\/\/doi.org\/10.1016\/S1470-2045(18)30687-9","journal-title":"Lancet Oncol"},{"key":"6219_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13045-021-01135w","volume":"14","author":"R Alonso","year":"2021","unstructured":"Joaquin Martinez-Lopez, Alonso R et al (2021) Making clinical decisions based on measurable residual disease improves the outcome in multiple myeloma. J Hematol Oncol 14:126\u2013129. https:\/\/doi.org\/10.1186\/s13045-021-01135w","journal-title":"J Hematol Oncol"},{"key":"6219_CR18","doi-asserted-by":"publisher","unstructured":"Wu Qiong L, Junru, Huang, Beihui et al (2019) Bortezomib containing regimen induced sequential autologous hematopoietic stem cell transplantation for Multiple myeloma - long-term follow-up results of 200 patients in a single center. Chin J Hematol 40(6):453\u2013459. https:\/\/doi.org\/10.3760\/cmaj.issn0253-2727.2019.06.002","DOI":"10.3760\/cmaj.issn0253-2727.2019.06.002"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06219-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06219-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06219-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T01:00:24Z","timestamp":1737680424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06219-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":18,"alternative-id":["6219"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06219-y","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We enrolled 11 symptomatic patients with MM who underwent ASCT at Dongguan Kanghua Hospital ( between July 2019 and December 2023). All patients gave informed consent, and the study was approved by the by the institutional ethics committee of the Dongguan Kanghua Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients and authors agreed to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All the authors agreed to publish the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}